Results

Total Results: over 10,000 records

Showing results for "stage".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - However, stage is the key determinant of the management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact. … Stage reclassification. … The change in stage of the cancer after imaging, compared with the stage determined based on information
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - However, stage is the key determinant of the management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact. … Stage reclassification. … The change in stage of the cancer after imaging, compared with the stage determined based on information
  3. nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Type_of_Care/Prevention
    February 19, 2021 - ever received pneumococcal vaccination 69.0 78.7 12.3% Breast cancer diagnosed at advanced stage … (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and … over 84.5 74.2 13.8% Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional … or distant stage) per 100,000 population age 50 and over 63.8 48.9 30.4% Cervical cancer … diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 10.5 7.7 36.0%
  4. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening
    July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … Stage II: 0.3% ( n = 4) vs. 0.2% (n = 2) Stage IIIA: 0.6% ( n = 7) vs. 0.3% ( n = 4) Stage … : 31/35     Stage IA: 20/16     Stage IB: 2/1     Stage IIA: 4/4     Stage IIB: 0 … /2     Stage IIIA: 2/4     Stage IIIB: 0/2     Stage IV: 1/0     Unknown: 0/2      … I: 58%   Stage II: 17%   Stage III: 30%   Stage IV: 7%   Additional procedures
  5. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
    July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … NR Stage IV: 17% vs. 15% vs. … : 31/35     Stage IA: 20/16     Stage IB: 2/1     Stage IIA: 4/4     Stage IIB: 0 … /2     Stage IIIA: 2/4     Stage IIIB: 0/2     Stage IV: 1/0     Unknown: 0/2      … I: 58%   Stage II: 17%   Stage III: 30%   Stage IV: 7%   Additional procedures
  6. effectivehealthcare-admin.ahrq.gov/products/lung-cancer-staging/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  7. cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
    January 01, 2012 - onto building decision support and putting it into practice 5 5 How We Designed Healthy Weight Stage … 1: Freehand mockup Stage 2 Wireframe mockup Stage 3 Interactive module Stage 4 User testing, feedback … Stage 5 Redesign, Enhance, Evaluate 6 Stage 1 Quick, easy, low overhead, adaptable Stage 2 Layout … , spacing, internal workflow (white box testing) Stage 3 Interactivity, data handling, processing speed
  8. effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
    July 18, 2017 - for localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 tumors … CKD stage ≥3: RR 0.88 (0.60 to 1.30) CKD stage ≥3b: RR 2.78 (0.47 to 16.54) CKD stage ≥4: RR 0.76 … CKD stage ≥3: RR 0.39 (0.30 to 0.51) CKD stage ≥3b: RR 0.37 (0.26 to 0.53) CKD stage ≥4: RR 0.76
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
    July 01, 2017 - localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 … CKD stage ≥3: RR 0.88 (0.60 to 1.30) CKD stage ≥3b: RR 2.78 (0.47 to 16.54) CKD stage ≥4: RR 0.76 ( … CKD stage ≥3: RR 0.39 (0.30 to 0.51) CKD stage ≥3b: RR 0.37 (0.26 to 0.53) CKD stage ≥4: RR 0.76 (0.54
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
    July 01, 2017 - localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 … CKD stage ≥3: RR 0.88 (0.60 to 1.30) CKD stage ≥3b: RR 2.78 (0.47 to 16.54) CKD stage ≥4: RR 0.76 ( … CKD stage ≥3: RR 0.39 (0.30 to 0.51) CKD stage ≥3b: RR 0.37 (0.26 to 0.53) CKD stage ≥4: RR 0.76 (0.54
  11. hcup-us.ahrq.gov/db/vars/ds_stage1/kidnote.jsp
    September 01, 2008 - TOOLS KID Description of Data Elements   DS_Stage1 - Disease Staging: Stage … This severity measure includes the disease category and stage for the principal diagnosis and predictive … Uniform Values Variable Description Value Value Description DS_Stage1 Disease Staging: Stage … of Principal Disease Category n.nn Principal Stage .
  12. hcup-us.ahrq.gov/db/vars/ds_stage1/nisnote.jsp
    September 01, 2008 - TOOLS NIS Description of Data Elements   DS_Stage1 - Disease Staging: Stage … This severity measure includes the disease category and stage for the principal diagnosis and predictive … Uniform Values Variable Description Value Value Description DS_Stage1 Disease Staging: Stage … of Principal Disease Category n.nn Principal Stage .
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - to 8 percent among beneficiaries in Stage I; from 13 percent to 7 percent in Stage II; from 23 percent … Stage II: The inclusion criteria for the stage II population included beneficiaries: (1) enrolled in … Stage IV: The inclusion criteria for the stage IV population included beneficia- ries: (1) enrolled in … Stage V: The inclusion criteria for the stage V population included beneficiaries: (1) enrolled in Part … Stage VI: The inclusion criteria for the stage VI population included beneficia- ries: (1) enrolled in
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - to 8 percent among beneficiaries in Stage I; from 13 percent to 7 percent in Stage II; from 23 percent … Stage II: The inclusion criteria for the stage II population included beneficiaries: (1) enrolled in … Stage IV: The inclusion criteria for the stage IV population included beneficia- ries: (1) enrolled in … Stage V: The inclusion criteria for the stage V population included beneficiaries: (1) enrolled in Part … Stage VI: The inclusion criteria for the stage VI population included beneficia- ries: (1) enrolled in
  15. www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
    April 15, 2012 - of ovarian tumors are diagnosed at this stage. … Additionally, the majority (72 percent) of screen-detected cancer cases were late-stage (Stage III or … Overall, 48.3 percent of the invasive cancer cases were early stage (Stage I or II), with no significant … stage distribution difference between the two groups. … might be more likely to identify early-stage, slow-growing tumors than later screening cycles.
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
    December 31, 2014 - , only 15 percent of ovarian tumors are diagnosed at this stage. … Additionally, the majority (72 percent) of screen-detected cancer cases were late-stage (Stage III … Overall, 48.3 percent of the invasive cancer cases were early stage (Stage I or II), with no significant … stage distribution difference between the two groups. … might be more likely to identify early-stage, slow-growing tumors than later screening cycles.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0491-140827.pdf
    February 19, 2014 - that there is insufficient clarity regarding the most effective imaging modalities to diagnose and stage … A review of the evidence on imaging modalities to diagnose and stage lung cancer could aid in the development
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0491-140827.pdf
    February 19, 2014 - that there is insufficient clarity regarding the most effective imaging modalities to diagnose and stage … A review of the evidence on imaging modalities to diagnose and stage lung cancer could aid in the development
  19. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/job-aid-model-pdsa.pdf
    May 17, 2021 - Four stages of a PDSA cycle Stage 1. … Stage 2. … Stage 3. Study – The practice analyzes the data collected during the Do stage. Stage 4.
  20. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/job-aid-model-pdsa.pdf
    May 17, 2021 - Four stages of a PDSA cycle Stage 1. … Stage 2. … Stage 3. Study – The practice analyzes the data collected during the Do stage. Stage 4.